Recurrent Disease Active Not Recruiting Phase 2 Trials for Nilotinib (DB04868)

IndicationStatusPhase
DBCOND0028541 (Recurrent Disease)Active Not Recruiting2
clinicaltrials.gov IdentifierTitlePurposeDrugs